Connective tissue growth factor (CTGF/CCN2) can be induced by various forms of stress such as exposure to high glucose, mechanical load, or hypoxia. Here, we investigated the molecular mechanism involved in the induction of ctgf/ccn2 by hypoxia in a human chondrosarcoma cell line, HCS-2/8. Hypoxia increased the ctgf/ ccn2 mRNA level by altering the 3 0 -untranslated region (UTR)-mediated mRNA stability without requiring de novo protein synthesis. After a series of extensive analyses, we eventually found that the cis-repressive element of 84 bases within the 3 0 -UTR specifically bound to a cytoplasmic/nuclear protein. By conducting a UV crosslinking assay, we found the cytoplasmic/nuclear protein to be a 35 kDa molecule that bound to the ciselement in a hypoxia-inducible manner. These results suggest that a cis-element in the 3 0 -UTR of ctgf/ccn2 mRNA and trans-factor counterpart(s) play an important role in the post-transcriptional regulation by determining the stability of ctgf/ccn2 mRNA.
Introduction
Hypoxia is a common microenvironmental condition in solid tumors and provides the potential to promote their malignant progression by altering gene expression (Shih and Claffey, 1998; Carmeliet and Jain, 2000; Kunz and Ibrahim, 2003) . These alterations induce the expression of tumorigenic proteins, including angiogenesis-regulatory proteins, metastasis-promoting proteins, and metabolic enzymes. These changes in expression can occur either at the transcriptional level, typically through changes in transcription rates, or at a post-transcriptional level, typically through changes in mRNA stability. Thus, understanding the profile of hypoxiainducible gene expression may provide clues of critical therapeutic importance for the treatment of malignancies.
Connective tissue growth factor (CTGF/CCN2), a member of the CCN (CTGF/CYR61/NOV) family, is a cysteine-rich secretory protein with a molecular weight of 36-38 kDa and having four distinct domains, that is, insulin-like growth factor binding protein (IGFBP), von Willebrand factor type C repeat (vWC), thrombospondin type 1 repeat (TSP-1), and COOH-terminal (CT) domains (Bradham et al., 1991; Bork, 1993; Brigstock, 1999; Kumar et al., 1999; Lau and Lam, 1999; Takigawa, 2003; Takigawa et al., 2003) . CTGF/CCN2 is a multifunctional growth factor, which can directly promote cell proliferation, chemotaxis, adhesion, and extracellular matrix (ECM) formation by mesenchymal cells. Recently, we found that hypoxia increased the expression of ctgf/ccn2 in a human breast cancer cell line, MDA231, by means of a 3 0 -untranslated region (UTR)-mediated increase in mRNA stability. Namely, transfection studies demonstrated that entire ctgf/ccn2 3 0 -UTR significantly repressed luciferase gene expression under normoxia and this effect was diminished when cells are challenged by hypoxia (Kondo et al., 2002) . Since CTGF/CCN2 is also known to be a potent angiogenic factor (Babic et al., 1999; Shimo et al., 1999a, b) , these changes play an important role in promoting tumor angiogenesis and progression of human malignant tumors. Therefore, the contribution of the 3 0 -UTR-mediated regulation of ctgf/ccn2 in promoting hypoxia-induced ctgf/ccn2 mRNA expression is indispensable for such malignant phenotypes. mRNA stability is an important mechanism for the regulation of gene expression (Ross, 1995) . The turnover of mRNAs is regulated by interactions among trans-acting factors (regulatory proteins) and specific sequences mostly located within the 3 0 -UTR of certain mRNAs (Chen and Shyu, 1995; Ross, 1995) . For example, the increase in the stability of vegf mRNA in response to hypoxia has been demonstrated to be mediated by interactions among specific 40 bp sequences in its 3 0 -UTR and HuR as one of such trans-acting factors (GoldbergCohen et al., 2002) . Thus, it is plausible that the hypoxic induction of the angiogenic properties of CTGF/CCN2 would be under the control of post-transcriptional regulation and that the 3 0 -UTR of ctgf/ccn2 mRNA would contain a cis-element that interacts with hypoxiarelated regulatory proteins. Nevertheless, the precise control mechanisms by such RNA-protein interaction upon hypoxia have not been defined so far.
In this study, we found that hypoxia-induced gene expression of human ctgf/ccn2 mRNA is regulated posttranscriptionally in a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8, and that a cis-element in the 3 0 -UTR of ctgf/ccn2 mRNA and trans-factor counterpart(s) play an important role in the posttranscriptional regulation by determining the stability of ctgf/ccn2 mRNA.
Results

Gene expression profile of hypoxic HCS-2/8 cells
The expression profile of a variety of genes in HCS-2/8 cells was compared between normoxic and hypoxic conditions by utilizing gene array technology. After having reached subconfluence, HCS-2/8 cells were placed under the normoxic or hypoxic condition for 6 h. A detailed computer comparison of the signals from the two blots led to the identification of 10 genes that took high ranks in their relative intensities of hypoxic versus normoxic signals (Table 1) . These genes included those for an ECM-remodeling protein (TIMP-1), transcription factors (FRA-1 and FRA-2), cytokines (IL-13 and IL-6), and growth factors (VEGF and CTGF/CCN2).
Hypoxia increased the steady-state ctgf/ccn2 mRNA level in HCS-2/8 cells The time course of ctgf/ccn2 gene expression was analysed in more detail by Northern blotting with RNA samples isolated after 1.5, 3, 6, 12, 18 , and 24 h of hypoxic exposure. As shown in Figure 1 , steady-state ctgf/ccn2 mRNA expression was maximally upregulated by 12 h of hypoxic exposure to a level approximately twofold higher than that under normoxia. These results firmly support the hypoxic induction of ctgf/ccn2 observed from the gene array analysis.
CTGF/CCN2 gene induction by hypoxia in HCS-2/8 cells is not due to the activation of the ctgf/ccn2 promoter, but is due to the increased stability of ctgf/ccn2 mRNA First, to elucidate whether the ctgf/ccn2 promoter region could mediate transcriptional responses to cellular hypoxia or not, we evaluated the activity of a proximal ctgf/ccn2 promoter under hypoxic conditions with a corresponding reporter plasmid. As the effects of hypoxia on the ctgf/ccn2 mRNA level had been prominently observed within 12 h (Figure 1 ), the promoter activity was also analysed within such a time frame. After having been exposed to hypoxia for 6 h, the transfected cells were assayed for luciferase activities. As shown in Figure 2a , the reporter gene expression under hypoxia showed no change in comparison with that Regulation of CTGF/CCN2 gene stability under hypoxia S Kondo et al under normoxia. This result demonstrates that activation of the ctgf/ccn2 promoter did not occur along with the ctgf/ccn2 gene induction by hypoxia, as observed in the case of MDA231 cells (Kondo et al., 2002) . Since the role of transcription cannot be ruled out by only using transient transfection with a promoter, a nuclear transcript run-on assay was performed. As shown in Figure 2b , transcription rates were the same in nuclei from either normoxic or hypoxic cells, in contrast to the twofold increase in the steady-state ctgf/ccn2 mRNA level as shown in Figure 1 . Therefore, the effect of hypoxia to increase the ctgf/ccn2 mRNA level is predominantly post-transcriptional in nature in HCS-2/8 cells. Next, we treated the cells with a protein synthesis inhibitor, CHX (10 mg/ml). Figure 2c shows that CHX did not prevent, but quite enhanced, the increase in the ctgf/ccn2 mRNA level under the hypoxic condition. These data suggest that pre-existing cellular proteins are sufficient to mediate the stabilization of ctgf/ccn2 mRNA. Finally, we performed quantitative real-time PCR analysis, following a time course after the addition of Act D (5 mg/ml) under hypoxia. As shown in Figure 2d , the half-life of ctgf/ccn2 mRNA under hypoxic conditions was prolonged by approximately twofold as compared with that under normoxia, indicating the increased stability of ctgf/ccn2 mRNA under hypoxia.
CAESAR/SA5 element in the ctgf/ccn2 3 0 -UTR mediates mRNA stabilization by hypoxia Since it is well established that the turnover rate of a given mRNA can be determined by interaction of transacting factors with specific cis-element located within its 3 0 -UTR (Chen and Shyu, 1995; Ross, 1995) , we comparatively analysed the regulation by the ctgf/ccn2 3 0 -UTR under normoxic and hypoxic conditions. The ctgf/ccn2 3 0 -UTR exhibits a potent repressive effect on luciferase gene expression in HCS-2/8 cells, as previously reported (Eguchi et al., 2001) . As shown in Figure 3b , the ctgf/ccn2 3 0 -UTR showed a significant difference in repressive effect on luciferase gene expression between the two conditions examined. The repressive potential under the hypoxic condition was diminished by 1.75-fold as compared with that under normoxia. According to the findings mentioned above, the increased steady-state level of ctgf/ccn2 mRNA in hypoxia-treated HCS-2/8 cells can be mostly ascribed to Regulation of CTGF/CCN2 gene stability under hypoxia S Kondo et al this dynamic regulation by the ctgf/ccn2 3 0 -UTR. We further analysed the possible involvement of the posttranscriptional regulatory mechanism through the 3 0 -UTR. The ctgf/ccn2 3 0 -UTR contains a cis-acting element of structure-anchored repression (CAESAR; Figure 3a ), which is a post-transcriptional RNA regulatory element of 84 bases, and has an important role in determining ctgf/ccn2 basal expression level in Cos7 cells (Kubota et al., 2000) . Suspecting another dynamic function therein, we performed cell-free RNA decay assays using RNA transcripts of this region. Capped and polyadenylated mRNAs were used in these assays to mimic in vivo decay, which likely involves capstimulated deadenylation by poly(A)-specific ribonuclease followed by rapid decay of the mRNA body (Korner et al., 1998; Ford and Wilusz, 1999; Dehlin et al., 2000) . Labeled luciferase-SA5 transcripts were synthesized by in vitro transcription reactions in which the Anti-reverse cap analog (ARCA) cap was added. Poly(A) tails of 150 nucleotides were subsequently added by the E-PAP enzyme, and the mRNAs were incubated with cytoplasmic extracts from normoxic and hypoxia-exposed cells. As shown in Figure 3c , luciferase-SA5 RNA incubated with the cytoplasmic extract ) and capped and polyadenylated mRNA (luciferase-SA5) used in these assays. The whole 3 0 -UTR was fused to a firefly luciferase cDNA in pGL3-control (Promega) to yield pGL3UTRS, as described previously (Kubota et al., 1999) . SA5 corresponds to CAESAR, and is located at the upstream end of the ctgf/ccn2 3 0 -UTR. The mRNA with SA5/CAESAR fragment, which was capped and polyadenylated in vitro, is illustrated in the lower panel. SVp, SV40 promoter; SVe, SV40 enhancer; polyA, SV40 polyadenylation signal; 3 0 -UTR, whole ctgf/ccn2 3 0 -UTR; Luciferase, firefly luciferase gene; CAESAR, cis-acting element of structure-anchored repression. Regulation of CTGF/CCN2 gene stability under hypoxia S Kondo et al from hypoxia-exposed cells decayed at a slower rate than that incubated with the corresponding extract from normoxia-exposed cells. This finding agrees with the prolonged half-life of ctgf/ccn2 mRNA under hypoxic conditions, which was observed in the degradation assay (Figure 2d ). Furthermore, we examined whether the observed effect can be seen in other cell types or not. Since the involvement of similar posttranscriptional regulatory mechanism through the 3 0 -UTR was previously suggested by transient reporter assays with MDA231 (Kondo et al., 2002) , and ctgf/ccn2 mRNA is highly expressed in human umbilical vein endothelial cells (HUVECs), these cell lines were forwarded to RNA decay assays. As shown in Figure 3d , similar results were obtained, suggesting that chondrosarcoma, adenocarcinoma, and even normal endothelial cells possess a common or similar mechanism in controlling the decay of CAESAR-containing mRNA. Therefore, our data suggest that the CAESAR/ SA5 cis-element in the 3 0 -UTR of ctgf/ccn2 mRNA plays an important role in the post-transcriptional regulation by determining the stability of ctgf/ccn2 mRNA under hypoxia.
An 84-base-long RNA is sufficient for binding to the cytoplasmic and nuclear protein(s) In order to confirm the binding of the SA5/CAESAR fragment, as well as the whole 3 0 -UTR, to certain cellular protein(s), we performed an RNA electromobility shift assay (REMSA) by incubating RNA transcripts around this regions of the 3 0 -UTR with the nuclear and cytoplasmic extracts from HCS-2/8 cells under normoxic or hypoxic conditions. In vitro transcripts containing the entire ctgf/ccn2 3 0 -UTR or its fragments containing deletions from the 3 0 end of the UTR were synthesized as described in Materials and methods. The denaturing polyacrylamide gel electrophoresis (PAGE) (Figure 4b ) showed an extra single band smaller than the expected one. We suppose this minor band to reflect termination of transcription caused by sequences homologous to the bacteriophage polymerase termination signals forming stem-loop structures (Macdonald et al., 1993 (Macdonald et al., , 1994 , which would explain the unexpected smaller transcripts. As shown in Figure 4a (right panel), the nuclear extract contained protein that formed a constitutive complex, which also appeared to be formed with the cytoplasmic extract; however, the pattern of complex formation was different between the nuclear and cytoplasmic extracts. Of importance, the intensity of the signals of the RNA-protein complex was increased when the HCS-2/8 cells were exposed to hypoxia for 6 h. Finally, subsequent competition analysis was performed using unlabeled transcripts of this region (Figure 4c ). Not only the deletion transcriptprotein complexes but also the entire ctgf 3 0 -UTRprotein complex could be completely inhibited by excess unlabeled SA5 transcript, suggesting that the SA5/ CAESAR fragment is sufficient to bind to the cytoplasmic and nuclear proteins.
Characterization of the SA5/CAESAR-binding proteins
To determine the size of the ctgf/ccn2 binding protein, we performed a UV crosslinking assay. As shown in Figure 5a , one major RNA-protein complex of approximately 35 kDa was resolved. The formation of this complex was substantially increased when nuclear and cytoplasmic protein extracts from HCS-2/8 cells that had been exposed to hypoxia were used. This finding supports the increased protein binding observed in REMSA with the same samples. Apparently, strong signals from the cytoplasmic fraction (compared to REMSA) might be due to signal accumulation that occurred during 10 min of irreversible crosslinking. To explore this point further, we conducted Northwestern analysis. As shown in Figure 5b , the SA5/CAESAR fragment showed distinct binding to three of the proteins. Of importance, one of the proteins at 35 kDa was led to an increase when nuclear protein extracts from HCS-2/8 cells that had been exposed to hypoxia were used. These results indicate that the element in the 3 0 -UTR of ctgf/ccn2 mRNA for binding to the hypoxiainducible 35 kDa trans-factor is present within the SA5/CAESAR region.
Hypoxia-increased CTGF/CCN2 production by HCS-2/8 cells and colocalization of CTGF/CCN2 and hypoxic tissue region in nu/nu HCS-2/8 xenografts To document CTGF/CCN2 induction by hypoxia at the protein level, we quantified by enzyme-linked immunosorbent assay (ELISA) the amount of CTGF/CCN2 formed following hypoxic treatment. As shown in Figure 6a , the CTGF/CCN2 levels in the supernatant and cell layer from cultures of HCS-2/8 cells exposed to hypoxia were significantly increased compared with those from the normoxic cells. This pattern of protein production seems to follow the steady-state mRNA level in the same cells, suggesting the former to be an outcome of the latter under the hypoxic condition. In order to confirm the above findings in vivo, we further examined immunolocalization of CTGF/CCN2 proteins in nu/nu mice bearing HCS-2/8 cell xenografts. Hypoxyprobet-1 was utilized for locating hypoxic regions within the tumor. As shown in Figure 6b , when the distribution of the immunosignal for CTGF/CCN2 was compared with that of hypoxic tissue regions, nearly complete correspondence in localization was observed. According to the findings described above, the increase in the level of ctgf/ccn2 mRNA due to the 3 0 -UTRmediated increase in mRNA stability, indeed, resulted in enhanced CTGF/CCN2 protein synthesis not only in vitro, but also in vivo under the hypoxic condition.
Discussion
In this study, we initially examined whether or not a hypoxic stimulus could induce the production of CTGF/ CCN2 in a human chondrosarcoma cell line, HCS-2/8. After confirming such hypoxic induction of CTGF/ CCN2, we subsequently investigated the underlying Regulation of CTGF/CCN2 gene stability under hypoxia S Kondo et al molecular mechanism governing CTGF/CCN2 induction. As a result, we found that hypoxia-induced gene expression of ctgf/ccn2 mRNA is not regulated transcriptionally in HCS-2/8 cells. Instead, we discovered that a CEASAR/84-based hypoxia-responsive region in the human CTGF 3 0 -UTR was critical for the stabilization of ctgf/ccn2 mRNA under hypoxia. This region was able to form hypoxia-inducible mRNA-protein complexes. Results from the UV crosslinking assay revealed that a 35 kDa cytoplasmic protein binds to the (full length, 466, 202, SA5) were subcloned in the pGEM4Zf( þ ), pGEM3Zf( þ ) vector and were used to generate sense 3 0 -UTR transcripts in vitro. Deletions from the poly(A) side of the UTR were produced with the designated restriction enzymes. Construct 'full length' contains the entire 3 0 -UTR and yields an RNA of 1096 bases. Construct 466 is derived from the XbaI-EcoRI fragment of pGL3SA2 and yields an RNA of 466 bases. Construct 202 is derived from the XbaI-EcoRI fragment of pGL3SA3 and yields an RNA of 202 bases. Construct SA5 is derived from the XbaI-EcoRI fragment of pGL3SA5 and yields an RNA of 84 bases. The locations of the pentameric instability consensus signals and stem-loop structure causing premature termination of transcription are depicted by open asterisk and open box, respectively. Construction of the original plasmids (pGL3SA2, pGL3SA3, pGL3SA5) was described in a previous report (Kubota et al., 2000) . Right panel: Analysis of the synthesized RNAs in 6% urea-denatured PAGE. Three 32 P-labeled RNAs (full length, 466, 202) were prepared, and the expected size for each RNA is indicated by an arrowhead. Analysis of the synthesized RNA (SA5) in 6% urea-denatured PAGE is already shown in the left panel of (a). Denaturing gel analysis shows the presence of an extra band smaller than the expected size for each RNA except SA5. This band was possibly caused by a sequence that formed the stem-loop structure (illustrated by the open box in the left panel), thus yielding unexpected smaller transcripts due to premature termination of transcription. (c) Competition analysis of the REMSA. A 500 ng portion of unlabeled RNAs (SA5) was preincubated with the extract. Then, radiolabeled probes (full length, 466, 202, SA5) were added and REMSA was carried out as described above. A 10 mg portion of nuclear extract (Nuc) or cytoplasmic extract (Cyto) prepared from HCS-2/8 cells under hypoxic conditions was used.
Regulation of CTGF/CCN2 gene stability under hypoxia S Kondo et al corresponding sequence of ctgf/ccn2 mRNA. According to these findings, we propose that the observed specific interaction of cytoplasmic proteins with ctgf/ccn2 mRNA may play an important role in hypoxia-induced post-transcriptional regulation of human ctgf/ccn2 mRNA by enhancing its stability. Generally, when cells are challenged by hypoxia, the expression of a number of hypoxia-responsive proteins is increased. Hypoxia-inducible factor 1 (HIF-1), a basic helix-loop-helix heterodimer consisting of HIF-1a and the aryl hydrocarbon nuclear translocator (ARNT), is a typical transcription factor activated by hypoxia (Wang and Semenza, 1993; Wang et al., 1995) . It binds to specific hypoxia-response elements (HRE) in the promoter of specific genes, such as vegf and erythropoietin (EPO; Levy et al., 1995) . It was earlier reported that Cyr61 expression is induced by hypoxia in melanoma cells and that HIF-1 interacts with c-Jun/activator protein-1 (AP-1) and thereby contributes to Cyr61 transcriptional regulation under hypoxia . Recently, involvement of HIF-1 in the hypoxic induction of ctgf/ccn2 was also suggested (Higgins et al., 2004) . Higgins et al. showed that HIF-1 could directly interact with HRE located in the 5 0 region of ctgf/ccn2 for increased promoter activity in response to hypoxia in primary renal epithelial cells. In addition, cells deficient in hif-1a were incapable of inducing ctgf/ccn2 mRNA in response to hypoxia, suggesting the critical requirement of HIF-1. On the other hand, our data do not permit us to conclude that hypoxia-mediated induction of ctgf/ ccn2 occurs at the transcriptional level. In fact, we observed that CHX did not prevent the increase in the ctgf/ccn2 mRNA level under the hypoxic condition, suggesting that the observed increase in ctgf/ccn2 mRNA level was not induced by increased synthesis of a nascent transcription factor(s), for example, HIF-1 and AP-1. Furthermore, the nuclear transcription rates After the cells had reached subconfluence, the medium was replaced with fresh medium, and the cells were placed under the normoxic (N) or hypoxic (H) condition for the indicated times. Then, the cell culture supernatant and cell layer fraction were harvested. Quantification of growth factor was performed using an ELISA system specific for CTGF/CCN2. Asterisks indicate significant differences from normoxia (**Po0.01). Results are presented as the means7s.d. of duplicates. (b) Localization of the hypoxic tissue regions and CTGF/CCN2 in nu/nu xenografts. Serial sections were reacted with an anti-CTGF serum and antiHypoxyprobe-1, and signals were visualized with immunoperoxidase. The applied concentration of each antibody was determined according to the manufacturer's protocol. No significant signals were seen in the control sections incubated with the secondary antibody only.
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showed no difference between the nuclei from normoxic and hypoxic HCS-2/8 cells, indicating that the major effect of hypoxia to increase ctgf/ccn2 gene expression is post-transcriptional in HCS-2/8 cells.
Since HCS-2/8 cells are derived from chondrosarcoma, which is basically avascular, increased mRNA stability during hypoxia may be a major mechanism to duly adapt the cells to a low oxygen tension through an HIF-1-independent pathway. Of note, it is already known that the expression of certain other hypoxiainduced genes (VEGF, EPO) is mediated by both increased transcription and mRNA stability (Levy et al., 1995 (Levy et al., , 1996a . Therefore, it is also possible that the overall induction of the ctgf/ccn2 gene is the combined consequence of induction of transcription and increased mRNA stability, which enables finely tuned modulation of the expression of ctgf/ccn2. As such, although our findings do not appear to support the finding of Higgins et al. (2004) , it is plausible that regulation of mRNA stability is a tissue-or cell typespecific activity that dominates, rather than a general regulation via HIF-1, in hypoxia-mediated regulation of ctgf/ccn2 mRNA expression in chondrocytic HCS-2/8 cells. Further investigations are required to fully account for the discrepancy between our results and those of Higgins et al.
Various RNA-binding proteins are involved in the regulation of splicing, processing, cytoplasmic export, translation, and finally decay of the mRNA in response to different stimuli (Dreyfuss et al., 2002) . It has been proposed that RNA-binding proteins (stability factors) bind to the AU-rich element of target mRNA and inhibit either the endonuclease activity or the deadenylase activity (Rajagopalan and Malter, 1994) . Indeed, some RNA-binding proteins (HuR, a member of the Elav-like protein family) could be localized differentially in the cell under hypoxic or normoxic conditions, and be involved in the hypoxic stabilization of VEGF mRNA (Rondon et al., 1991; Fan and Steitz, 1998; Levy et al., 1998) . These findings indicate an intriguing possibility that such RNA-binding proteins may regulate mRNA stability by shuttling between the nucleus and the cytoplasm. In this study, we showed that a hypoxic-inducible nuclear/cytoplasmic protein of approximately 35 kDa bound to the minimal sequence of ctgf/ccn2 3 0 -UTR mRNA. This 84 bp 3 0 -UTR sequence, termed CAESAR, was capable of forming a unique stem-loop secondary structure (Kubota et al., 2000) . When linked in cis, CAESAR/SA5 was found to maintain the basal gene expression at a low level through the interference with translation process (Kubota et al., 2000 , which can be defined as the constitutive function of CAESAR/SA5. In addition to this classical function, we here uncovered another dynamic function of CAESAR as a post-transcriptional regulatory element, which was exerted by regulating mRNA stability. Therefore, CAESAR/SA5 mediates two different post-transcriptional regulatory events, probably through the interaction with multiple cofactors. Furthermore, increased stability of the reporter mRNA with this minimal sequence was observed upon hypoxia in plural cell types. In view of the increased stability of ctgf/ccn2 mRNA and concomitant increase in this RNA-protein interaction during hypoxia, it is reasonable to hypothesize that the binding of this 35 kDa protein to the 3 0 -UTR sequence is involved in the regulation of ctgf/ccn2 mRNA stability during hypoxia. The 3 0 -UTRs of other hypoxia-upregulated genes, for example, VEGF, EPO, and tyrosine hydroxylase (TH), were shown to interact with mRNAbinding proteins having molecular masses ranging from 34 to 140 kDa (Rondon et al., 1991; Czyzyk-Krzeska et al., 1994; Shih and Claffey, 1999) . Increased formation of such mRNA-protein complexes was also observed during hypoxia, was thus involved in the stabilization of these mRNAs. Although the interaction sites for hypoxia-inducible protein in the VEGF or TH 3 0 -UTRs, which are highly AU-rich elements, lack significant homology with the 35 kDa cytoplasmic protein binding site of ctgf/ccn2 mRNA in nucleotide sequence, formation of stem-loop secondary structure is a common feature of these targets of RNA-binding proteins. Therefore, it is plausible that this structure is required for hypoxia-induced protein binding of ctgf/ccn2 mRNA.
Since the possibility that plural proteins are involved in the formation of the mRNA-protein complex via a protein-protein interaction cannot be ruled out, the 35 kDa ctgf/ccn2 mRNA binding protein may also be involved in another protein complex that recognizes another hypoxia-inducible gene. A clearer understanding of the mechanism of this regulation requires the identification and characterization of the trans-acting factors that interact with these elements. Currently, work is in progress to identify these proteins.
In conclusion, we demonstrated herein that hypoxiainduced gene expression of human ctgf/ccn2 mRNA is regulated post-transcriptionally in human chondrosarcoma-derived chondrocytic cell line, HCS-2/8, and that a cis-element in the 3 0 -UTR of ctgf/ccn2 mRNA and trans-factor counterparts play an important role in the post-transcriptional regulation by determining the stability of ctgf/ccn2 mRNA. This novel hypoxia-related regulatory system of gene expression may reflect a specific mode of biological response of chondrosarcomas and, possibly, of normal chondrocytes as well.
Materials and methods
Cell culture and hypoxic condition
The human chondrocytic cell line HCS-2/8, established from a chondrosarcoma, has chondrocytic properties exemplified by gene expression and production of type II collagen and aggrecan (Takigawa et al., 1989) . MDA231 cells were derived from a human breast cancer cell line (Kondo et al., 2002) . These cells were maintained at 371C in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) in a 5% CO 2 atmosphere. The HUVECs derived from human umbilical cords were purchased from Biowhittaker (Walkersville, MD, USA) and used between passages three and seven. These cells were cultured in EBM-2 complete medium (Clonetics, San Diego, CA, USA). Hypoxia experiments were performed in a humidified triple gas model BL-40M incubator (BIO-LABO, Tokyo, Japan) calibrated to deliver 5% CO 2 , 1% O 2 , and 94% N 2 at 371C. In a few experiments, Act D and CHX (Sigma Aldrich, St Louis, MO, USA) were used to arrest de novo mRNA and protein synthesis, respectively.
Collection of conditioned medium and total RNA For almost all of the experiments, the medium of subconfluent cultures was replenished with fresh medium containing 10% FBS, and the cells were then incubated overnight before hypoxic exposure. Total cellular RNA was harvested at each time for Northern blot, real-time PCR, and mRNA degradation analyses. In the experiments whose results are shown in Figure 6a , the medium was replaced with that containing minimal (0.5%) FBS, and the cells were directly placed under the normoxic or hypoxic condition for the desired time. Then, the cell culture supernatant and cell layer fraction were harvested for subsequent ELISA analysis.
Preparation of probes
We had formerly constructed firefly luciferase-ctgf/ccn2 chimeric gene constructs (pGL3UTRS, pGL3SA2, pGL3SA3, pGL3SA5), as described by Kubota et al. (1999 Kubota et al. ( , 2000 . For the preparation of template plasmids for in vitro transcription of full-length ctgf/ccn2 3 0 -UTR, these pGL3 derivatives were double-digested with XbaI and EcoRI, and the 3 0 -UTR fragments were purified and subcloned between the corresponding sites in pGEM3Zf( þ ) (Promega, Madison, WI, USA). The SA5 template plasmid was obtained by digestion of pGL3SA5 with XbaI-EcoRI, which was followed by ligation of the smaller digestion products between the corresponding sites of pGEM4Zf( þ ) (Promega). The plasmids were linearized by EcoRI (full length, 202, SA5) and AflII (466) and transcribed in vitro by bacteriophage T7 (202, SA5) or SP6 (full length, 466) RNA polymerase in the presence of 50 mCi of [a-32 P]CTP (3000 Ci/mmol; Amersham Pharmacia) for the preparation of radiolabeled sense RNA. The transcription reaction was performed at 371C for 1 h with the reagents supplied by the manufacturer (Promega), followed by RQ1 DNase (Amersham Pharmacia) digestion and spin-column (ProbeQuant G-50; Amersham Pharmacia) purification. After spin-column purification, the radiolabeled RNAs were analysed by 6% PAGE in the presence of 7 M urea in 1 Â Trisborate-EDTA (TBE) buffer.
RNA in vitro folding was carried out as previously described (Kubota et al., 2000; Mukudai et al., 2005) with a slight modification. Radiolabeled RNAs (5000 c.p.m.) were heated at 951C for 10 min and then gradually cooled to room temperature in an RNA folding buffer consisting of 10 mM HEPES (pH 7.9), 40 mM KCl, 3 mM MgCl 2 , 1 mM dithiothreitol (DTT), 0.5 mg/ml yeast tRNA (Boehringer Mannheim, Mannheim, Germany), and 0.5 mg/ml bovine serum albumin (BSA). RNA molecular size standards were produced via in vitro transcription of a mixture of DNA templates (Century Marker; Ambion, Austin, TX, USA) in the presence of [a-32 P]CTP. The radiolabeled RNA transcripts were subjected to spin-column purification, and 1.5 Â 10 4 c.p.m. was used as an RNA molecular standard in each experiment.
Plasmid constructs and DNA transfection
The firefly luciferase-ctgf/ccn2 chimeric gene construct, pGL3UTRS, has already been described by Kubota et al. (1999) . A ctgf/ccn2 promoter-driven firefly luciferase expression plasmid was obtained from Japan Tobacco Inc. HCS-2/8 cells were transfected with the construct using a cationic liposome reagent, Fugene 6 (Roche, Basel, Switzerland). The optimal amount of transfected plasmids and the time scale of the pretransfection period after seeding of HCS-2/8 cells were described previously (Eguchi et al., 2001) . At 24 h after transfection, the cells were placed under the normoxic or hypoxic condition for 6 h. The cells were then lysed in 500 ml of a passive lysis buffer (Promega), and the cell lysate was directly used in the luciferase assay, as described below.
Luciferase assay
The Dual Luciferase System (Promega) was used for the sequential measurement of firefly and Renilla luciferase activities with specific substrates of beetle luciferin and coelenterazine, respectively. Quantification of both luciferase activities was performed manually with a luminometer (TD-20/20; Turner Designs, Sunnyvale, CA, USA), and calculation of relative ratios was carried out.
Gene arrays
The Atlas human 1.2 cDNA expression arrays (Clontech, Palo Alto, CA, USA) were used to search for genes that are differentially expressed between hypoxic and normoxic conditions in HCS-2/8 cells. A list of genes represented on the macroarrays is available on the clontech website (http:// www.clontech.com). Polyadenylated (poly(A)) RNA isolation, [ 32 P]cDNA probe labeling, hybridization, and high-stringency washing were performed by following the protocols of the cDNA array kit provided by the manufacturer. Briefly, poly(A) RNAs were separated from the total RNA by chromatography on oligo(dT) beads, and then used to prepare 32 P-labeled cDNA probes with the use of Moloney murine leukemia virus reverse transcriptase and Atlas human 1.2 CDS primer mix (Clontech). The 32 P-labeled probes were purified by column chromatography, denatured for 20 min at 651C in 0.1 M NaOH containing 10 mM EDTA, and neutralized with an equal volume of 1 M sodium phosphate, pH 7.0, for 10 min. The microarray membranes were first exposed for 30 min at 651C to ExpressHyb solution (Clontech) containing100 mg/ml of heat-denatured sheared salmon testis DNA, after which they were hybridized overnight at 651C with 32 P-labeled cDNA and Cot-1 DNA (Clontech). The array was then thoroughly washed twice for 15 min at 651C with 2 Â standard saline citrate (SSC) containing 1% sodium dodecyl sulfate (SDS) and twice for 15 min at 651C with 0.1 Â SSC containing 0.5% SDS. The intensity of hybridization signals was quantified using an Array Gauge (Fujifilm, Tokyo, Japan) and normalized against the internal controls (a-tubulin, b-actin) on the same blot.
Nuclear run-on analysis Nuclear run-on assays were carried out according to an established protocol (Ratnam et al., 2002) with a slight modification. Induction of ctgf/ccn2 transcription by Dex (Sigma) at the dose of 100 nM was performed as reported previously . The nuclei from positive control (Dex), normoxic, or hypoxic-exposed cells were isolated, suspended in 50 mM Tris-HCl (pH 8.0), 40% glycerol, 5 mM MgCl 2 , and 0.1 mM EDTA, and aliquots were incubated at 301C for 2 h with a mixture of ATP, CTP, and GTP (2.5 mM each) and 100 mCi of [a-32 P]UTP (3000 Ci/mmol; Amersham Pharmacia, Aylesbury, UK) in a reaction buffer consisting of 10 mM Tris-HCl (pH 8.0), 5 mM MgCl 2 , and 300 mM KCl. After RQ1 DNase and proteinase K (Invitrogen, Carlsbad, CA, USA) digestion, the radiolabeled transcripts were extracted by Isogen LS (Nippon Gene, Tokyo, Japan) according to the manufacturer's protocol, and further purified by a spin column. The pGEM3Zf( þ ) human ctgf/ccn2 vector containing a full-length ctgf/ccn2 open reading frame was utilized as a probe for the ctgf/ccn2 gene. The probe for the human b-actin gene was obtained by conducting RT-PCR, utilizing total cellular RNA of HUVECs as a template. The nucleotide sequences of sense and antisense primers for human b-actin were 5 0 -accttctacaatgagctgcg-3 0 and 5 0 -tgtgcaat caaagtcctcgg-3 0 , respectively. The amplicons were subcloned into pGEM T-Easy (Promega) by a TA-cloning method. For preparation of membranes, the plasmids containing human bactin and ctgf/ccn2 were linearized by PstI and EcoRI, respectively, whereas pGEM3Zf( þ ), for background control, was linearized by HindIII. The plasmids were subjected to alkaline denaturation and then 10 mg of each was dot-blotted onto a nylon membrane by a Bio-Dot apparatus (Bio-Rad, Hercules, CA, USA). Radiolabeled nuclear transcripts (10 7 c.p.m./ml) were hybridized to the blotted membranes at 421C for 72 h in a hybridization buffer consisting of 5 Â SSC (pH 7.0), 5 Â Denhardt's solution (1 Â Denhardt's solution ¼ 0.002% polyvinylpyrrolidone, 0.02% Ficoll 400, and 0.02% BSA; Sigma Aldrich), 2% SDS, 50% formamide, and 100 mg/ml of sonicated salmon testis DNA (Sigma Aldrich). After hybridization, the membranes were washed at 651C for 20 min twice in a wash buffer composed of 0.1 Â SSC (pH 7.0) and 0.1% SDS and then subjected to autoradiography.
Northern blot analysis
Total cellular RNA was isolated from HCS-2/8 cells using Trizol reagent (Life Technologies, Rockville, MD, USA). Northern blot analysis was performed essentially as described previously (Kondo et al., 2002) . A 20 mg portion of total cellular RNA was subjected to electrophoresis on a 1% formaldehyde-agarose gel and transferred onto a Hybond-N filter (Amersham Pharmacia Biotech). Full-length human ctgf/ccn2 cDNA was radiolabeled and used as a probe.
Quantitative real-time PCR Total cellular RNA was isolated as described above, and a cDNA mixture was generated by reverse transcription using oligo(dT) as a primer by an avian myelosarcoma virus reverse transcriptase (Invitrogen, San Diego, CA, USA). The cDNA was used as a template in the subsequent PCR analysis using FastStart DNA Master SYBR Green I and a Light Cycler apparatus (Roche). The primers used were as follows: for ctgf/ccn2, 5 0 -tgactgccccttcccgagaa-3 0 and 5 0 -tcttccagtcgg taggcagctagg-3 0 ; and for b-actin, 5 0 -gatcattgctcctcctgagc-3 0 and 5 0 -actcctgcttgctgatccac-3 0 . Initial denaturation at 951C for 10 min was followed by 45 cycles of denaturation at 951C for 15 s, annealing at 551C for 10 s, and elongation at 721C for 10 s. The fluorescence intensity of the double-strand-specific SYBR Green I, reflecting the amount of PCR product formed, was monitored at the end of each elongation step. The b-actin mRNA levels were used to normalize the sample cDNA content.
Preparation of nuclear and cytoplasmic extracts
The nuclear and cytoplasmic extracts were prepared using a CelLytic nuclear extraction kit (Sigma Aldrich) according to the manufacturer's protocol. The protein concentrations of both fractions were determined using a BCA protein assay kit (Pierce, Rockford, IL, USA), utilizing BSA as a standard.
RNA electromobility shift assay REMSA was carried out according to the method described previously (Hew et al., 1999 (Hew et al., , 2000 , with a slight modification. The nuclear or the cytoplasmic extract containing 0-10 mg protein was incubated at 251C for 30 min with 5 Â 10 4 c.p.m. of radiolabeled RNA in 19 ml of binding buffer (5 mM HEPES (pH 7.9), 7.5 mM KCl, 0.5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM DTT, 0.1 mg/ml yeast tRNA, and 0.1 mg/ml BSA). Then, the binding mixture was incubated with 1 ml of 1/100 diluted RNase Cocktail (0.5 U/ml RNase A and 20 U/ml RNase T1; Ambion) for a further 10 min at 371C. The RNA-protein complex was subjected to 6% native PAGE in 0.5 Â TBE buffer. The gels were subsequently dried and autoradiographed. For competition experiments, the extracts were preincubated with 20 ng of unlabeled competitor RNA for 30 min at 251C, and then incubated with the radiolabeled RNA for another 30 min at 251C.
UV crosslinking assay RNA-protein binding reactions were carried out as described in the RNA electromobility shift assay section. After RNase digestion, the protein-RNA complexes were kept on ice and UV-irradiated for 10 min by a UV crosslinker (Amersham Pharmacia). Then, the samples were heated at 951C for 5 min in an SDS sample buffer (Sigma Aldrich) in the presence of 5% 2-melcaptoethanol, after which the complexes were separated by 12.5 or 4-20% gradient SDS-PAGE. The gels were subsequently dried and autoradiographed.
Western blot analysis and Northwestern analysis
Western blot analysis of fraction markers was carried out according to the method described previously . For Northwestern analysis, protein extracts were electrophoresed on SDS-polyacrylamide gels and electrotransferred onto polyvinylidene difluoride membrane (Hybond P, Amersham Biosciences). The membrane was incubated in blocking buffer (10 mM Tris (pH 7.5), 50 mM KCl, 5 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, 1 mg/ml yeast tRNA, 5% skim milk) for 18 h at 41C. Thereafter, it was incubated with the RNA probe (1 Â 10 6 c.p.m./ml) in binding buffer (10 mM Tris (pH 7.5), 50 mM KCl, 5 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, 1 mg/ml yeast tRNA, 0.25% skim milk) for 4 h at 301C. The membrane was washed four times at room temperature for 15 min with wash buffer (10 mM Tris (pH 7.5), 50 mM KCl, 1 mM EDTA, 1 mM DTT), and RNA binding to the proteins was visualized by autoradiography.
In vitro cell-free mRNA decay assay A coding region of the firefly luciferase gene flanked downstream by an 84-nucleotide fragment of the ctgf/ccn2 3 0 -UTR was subcloned from pGL3 SA5 into the pGEM4Zf( þ ) utilizing unique XbaI-EcoRI sites, which resulted in the plasmid pGEM4Zf( þ )-Luc-SA5. EcoRI-linearized pGEM4Zf( þ )-Luc-SA5 was used as a template for synthesis of luciferase-SA5 transcripts. Then 5 0 -capped polyadenylated and [ 32 P]UTP-labeled transcripts were prepared using the mMessage mMachine T7 kit according to the manufacturer's instructions (Ambion, Austin, TX, USA). Unincorporated NTPs were removed by spin-column chromatography. Approximately 80 000 c.p.m. of capped and polyadenylated luciferase-SA5 RNAs was used per each decay reaction. Decay assays were performed by incubating the transcript with 100 mg of cytoplasmic extract in a total volume of 70 ml (master mix) in IVDA buffer (10 mM Tris (pH 7.5), 100 mM potassium acetate, 2 mM magnesium acetate, 2 mM DTT, 10 mM creatine phosphate, 1 mM ATP, 0.4 mM GTP, 0.1 mM spermine) for the desired time at 301C. The reaction was stopped by transferring 10 ml aliquots from this master mix to 50 ml of ISOGEN-LS reagent (Nippon Gene, Tokyo, Japan), and the RNA was immediately extracted. RNA samples were then electrophoresed on a 6% polyacrylamide-7 M urea gel. After electrophoresis, the gels were fixed, dried, and analysed by commercial computer software, Quantity One (PDI Inc., New York, NY, USA).
Enzyme-linked immunosorbent assay
A sandwich ELISA for CTGF/CCN2 was carried out as described previously (Kondo et al., 2002) . This system had been developed with two different anti-human CTGF/CCN2 antibodies, one specific for the CT domain and the other for the VWC domain. After a 10 min incubation at room temperature, the amount of CTGF/CCN2 in each 50 ml sample was determined as the fluorescence intensity emitted at 460 nm from each well of the ELISA plate (excitation: 360 nm), which was measured using a Cytoflor 2300 system (Millipore Corp., MA, USA).
Preparation of solid tumors in vivo HCS-2/8 (1 Â 10 7 ) cells were injected subcutaneously into nude mice (nu/nu, 4-week-old males) and were maintained for 4 weeks. The intraperitoneal injection of Hypoxyprobe TM -1 (Chemicon International, Temecula, CA, USA) for the detection of tissue hypoxia was performed at a dose of 60 mg/kg body weight as indicated by the manufacturer's protocol. At 30 min after the injection, the mice were killed and specimens from subcutaneous tumors were processed for histological and immunohistochemical examination. The experiment was approved by the animal committee of the dental school.
Histological and immunohistochemical analyses
Portions of the tissues were fixed in 4% paraformaldehydephosphate-buffered saline (PBS), dehydrated, embedded in paraffin, sectioned, and processed for histopathological evaluation by hematoxylin-eosin and alcian blue staining.
For immunohistochemistry, the sections were deparaffinized, rehydrated, and digested for 30 min with hyaluronidase (25 mg/ml) in PBS. The samples were then incubated in a moist chamber at 41C overnight with an anti-CTGF/CCN2 antibody diluted 1:100 with PBS and anti-Hypoxyprobet-1 antibody diluted 1:50 with PBS. After the sections had been rinsed with PBS, horseradish peroxidase-conjugated secondary antibody was applied, and the sections were incubated for 2 h at room temperature. Color was developed using 3, 3 0 -diaminobenzidine tetrachloride. Finally, the sections were counterstained with methyl green.
Statistical analysis
Unless otherwise specified, all the experiments were repeated at least twice, with similar results. Statistical analysis was carried out by Student's t-test, if necessary. Data were expressed as the mean7s.d., and differences were considered significant at *Po0.05 and **Po0.01.
